Merck | MRK - Umlaufvermögen

Aktienkurs
111.85
Täglich Wechseln
-2.77 -2.42%
Monatlich
-6.30%
Jährlich
35.18%
Q2 Prognose
116.45




Umlaufvermögen Veränderung Datum
AbbVie USD 29.06B 523M 2025-12
Abbott USD 26B 1.16B 2025-12
ALKERMES USD 1.93B 187.5M 2025-12
Amgen USD 29.06B 1.17B 2025-12
AstraZeneca USD 28.72B 1.22B 2025-12
Biogen USD 8.97B 37.5M 2025-12
Bristol-Myers Squibb USD 35.63B 2.41B 2025-09
Coherus Biosciences USD 206.71M 254.25M 2025-12
Drreddys Laboratories INR 3.31B 164.26M 2025-12
Eli Lilly USD 55.63B 6.44B 2025-12
Gilead Sciences USD 19.89B 1.05B 2025-12
GlaxoSmithKline GBP 17.51B 332M 2025-12
Glaxosmithkline GBP 23.59B 390.44M 2025-12
J&J USD 59.17B 3.55B 2026-03
Medtronic USD 24.07B 75M 2025-12
Merck USD 47.56B 10.49B 2025-09
Novartis USD 30.46B 2.26B 2025-12
Novartis USD 30.46B 2.26B 2025-12
Novo Nordisk DKK 172.45B 9.43B 2025-12
Pacira USD 547.97M 14.78M 2025-12
Perrigo USD 2.8B 81.8M 2025-12
Pfizer USD 46.92B 3.22B 2025-09
Phibro Animal Health USD 862.18M 26.39M 2025-12
Prestige Brands USD 433.43M 63.98M 2025-12
Regeneron Pharmaceuticals USD 18.02B 41.2M 2025-12
Roche Holding CHF 38.73B 3.03B 2025-12
Sanofi EUR 30.16B 789M 2026-03
Sanofi EUR 30.95B 8.99B 2025-12
United Therapeutics USD 3.7B 208.5M 2025-12
Zoetis USD 6.77B 185M 2025-12